Organ transplantation is a gift of life. A second chance to live made possible by an organ donor. Unfortunately, transplanted patients are a high-risk population for COVID-19. But thanks to technology, it is possible to help optimize the treatment of these patients and thus, save them from losing the transplant and/or losing their life.
In the current pandemic situation due to the new SARS-CoV2 coronavirus (COVID-19), the presentation of the disease and the severity of the infection are higher in solid organ transplanted patients (kidney, pancreas, liver, heart, lung, intestine and multivisceral tranplants, as well as vascularized composite allograft). Also, the treatment, management and efficacy of the immune system in COVID-19 positive patients will influence the evolution and cure of the disease.
This project aims to create an international database that includes all solid organ transplanted patients with COVID19 infection. This database will include anonymized data regarding medical history, transplant history, medication and COVID19 history. Then, a Decision Support Algorithm (DSA) will be developed and trained, derived from the already available information on the database, to explore and predict outcomes.
Our long-term goal is to provide a global perspective regarding the influence of COVID-19 on solid organ transplantations, both on donation activity as well as on transplant outcomes. This effort can only be accomplished by an international altruistic collaboration, with data entry by each centre.
